Cornerstone Pharmaceuticals
Cranbury, United States (US) · Health and Medical
Do your work at Cornerstone Pharmaceuticals?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Overview
Cornerstone Pharmaceuticals is a US-based, clinical-stage metabolic oncology therapeutics company, dedicated to transforming cancer treatment.
We are pioneering research in altered cancer metabolism, developing first-in-class drugs and drug delivery technologies targeting enzymes within cancer cells’ mitochondria. Our focus is on creating highly selective and effective anti-cancer agents with minimal impact on healthy tissues, representing a significant advancement in cancer therapy.
CPI-613, our lead drug, is currently undergoing Phase I, II, and III clinical trials as a single agent and in combination with standard treatments. We are committed to providing rare science, rare compassion, and rare solutions for patients battling hard-to-treat cancers.
We are pioneering research in altered cancer metabolism, developing first-in-class drugs and drug delivery technologies targeting enzymes within cancer cells’ mitochondria. Our focus is on creating highly selective and effective anti-cancer agents with minimal impact on healthy tissues, representing a significant advancement in cancer therapy.
CPI-613, our lead drug, is currently undergoing Phase I, II, and III clinical trials as a single agent and in combination with standard treatments. We are committed to providing rare science, rare compassion, and rare solutions for patients battling hard-to-treat cancers.
Contact Details
info@cornerstonepharma.com
Cranbury, United States (US), 520 Broad Street
Company Type
Private Limited Company
Employees
10-20
Categories
Keywords
#oncology
Listings
Products
Companies teams usually look at after Cornerstone Pharmaceuticals
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.
